Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Fierce Pharma
Sanofi buys Blueprint for $9.1B, its largest deal in 7 years
After signaling its intent to make "bolt-on acquisitions," Sanofi has taken a major plunge, buying out Blueprint Medicines for $9.5 billion.
Kevin Dunleavy
Jun 2, 2025 11:09am
Sanofi pays $15M for another STAT6 degrader from Nurix collab
Jun 2, 2025 9:50am
Sanofi's IL-33 drug fails COPD study
May 30, 2025 5:30am
Sanofi inks $470M Vigil buyout to snag Alzheimer's prospect
May 22, 2025 4:49am
Sanofi axes IGM pact, sparking 80% layoffs at the biotech
May 9, 2025 3:59am
Recursion streamlines pipeline following merger with Exscientia
May 5, 2025 11:00am